REQUEST A DEMO
Total
USD $0.00
Search more companies

Aj Biologics Sdn. Bhd. (Malaysia)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Aj Biologics Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Aj Biologics Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kuala Lumpur. It operates in the Biological Product (except Diagnostic) Manufacturing industry. The enterprise was incorporated on June 07, 2013. There was a net sales revenue increase of 42.61% reported in Aj Biologics Sdn. Bhd.’s latest financial highlights for 2021. Its’ total assets recorded a negative growth of 37.14%. In 2021, Aj Biologics Sdn. Bhd.’s net profit margin increased by 285.16%.

Headquarters
Suite 2-03, 2Nd Floor Menara Atlan, 161B, Jalan Ampang
Kuala Lumpur; Federal Territories; Postal Code: 50450

Contact Details: Purchase the Aj Biologics Sdn. Bhd. report to view the information.

Website: http://www.ajbiologics.com/

Basic Information
Outstanding Shares:
Purchase the Aj Biologics Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Aj Biologics Sdn. Bhd. report to view the information.
Incorporation Date:
June 07, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Aj Biologics Pte. Ltd.
100%
Company Performance
Financial values in the chart are available after Aj Biologics Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
42.61%
Total operating revenue
42.61%
Operating profit (EBIT)
70.79%
EBITDA
70.99%
Net Profit (Loss) for the Period
70.79%
Total assets
-37.14%
Total equity
-19.11%
Operating Profit Margin (ROS)
285.16%
Net Profit Margin
285.16%
Return on Equity (ROE)
113.53%
Quick Ratio
37.96%
Cash Ratio
31.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?